Recruiting studies: Age Related Macular Degeneration Amd

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Personalized Monitoring of Non-foveal, Non-vision Compromising Atrophic Age-related Macular Degeneration With Artificial
Phase N/A · 7 location(s) · Medical University of Vienna · NCT06351657 The Role of Toll-like Receptor-4 in Periodontitis Patients With End-stage Renal Disease in a Sample of Egyptian Populati
Phase N/A · 1 location(s) · Ain Shams University · NCT06755372 Defining Retinal Structures Using Hyperspectral Retinal Imaging
NA · 1 location(s) · Center for Eye Research Australia · NCT07555574 The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, DR and Glaucoma
EARLY_Phase 1 · 1 location(s) · MCPHS University · NCT06593405 Safety and Efficacy of RRG001 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)
Phase 1/Phase 2 · 1 location(s) · Shanghai Refreshgene Technology Co., Ltd. · NCT06141460 A Study to Evaluate the Efficacy and Safety of IBI302inSubjects With nAMD
Phase 2 · 1 location(s) · Innovent Biologics Technology Limited (Shanghai R&D Center) · NCT07275840 Treatment of Neovascular AMD: Artificial Intelligence in Real-world Setting
Phase 4 · 1 location(s) · Medical University of Vienna · NCT05093374 MMP-9 Inhibition for Recalcitrant Wet AMD
Phase 2 · 1 location(s) · University of Iowa · NCT04504123 Lutein, Zeaxathin, and Fish Oil Supplementation
NA · 1 location(s) · Texas A&M University · NCT06489873 Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degener
Phase N/A · 1 location(s) · Ray Therapeutics, Inc. · NCT06375239 Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geog
Phase 1/Phase 2 · 5 location(s) · AbbVie · NCT07160179 Predicting Risk of Progression of Early to Late AMD in the Aging Eye Through Imaging and Multimodal Evaluation
Phase N/A · 2 location(s) · Singapore National Eye Centre · NCT07653269 Mecobalamin Combined With Anti-VEGF Intravitreal Injection for Retinal Vein Occlusion Treatment
Phase 4 · 1 location(s) · First Affiliated Hospital of Chongqing Medical University · NCT07133438 Progression of Early Atrophic Lesions
Phase N/A · 1 location(s) · University of Utah · NCT05959005 A Long-term Follow up Study of EXG102-031 in Participants With wAMD
Phase N/A · 1 location(s) · Guangzhou Jiayin Biotech Ltd · NCT06859515 A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participant
Phase 3 · 36 location(s) · Amgen · NCT07614776 An Clinical Study Evaluating the Safety, Tolerability, and efficAcy of HG005 in StaRgardT Disease
EARLY_Phase 1 · 1 location(s) · HuidaGene Therapeutics Co., Ltd. · NCT07063251 A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
Phase 2 · 80 location(s) · Boehringer Ingelheim · NCT06962839 Proteomic Biomarker Identification in Age-Related Macular Degeneration, Diabetic Retinopathy and Retinal Detachment
NA · 1 location(s) · Fondazione G.B. Bietti, IRCCS · NCT07500324 Post-market Clinical Investigation of the SING IMT System, Model NG SI IMT 3X in Patients With End-stage Age-related Mac
NA · 13 location(s) · VisionCare, Inc. · NCT04796545 Safety and Efficacy of Autologous Transplantation of iPSC-RPE in the Treatment of Macular Degeneration
Phase 1 · 1 location(s) · Beijing Tongren Hospital · NCT05445063 Mechanical Properties of the Internal Limiting Membrane and Intraoperative Utility of Brilliant Blue g (Bbg) and Indocya
Phase N/A · 3 location(s) · University Hospital, Basel, Switzerland · NCT01485575 Safety of BBC1501 Intravitreal Injection in Patients With Neovascular Age-Related Macular Degeneration (nAMD)
Phase 1 · 2 location(s) · Benobio Co., Ltd. · NCT05803785 Factors in Learning And Plasticity: Macular Degeneration
NA · 1 location(s) · University of Alabama at Birmingham · NCT05454124 Gene Therapy(FT-003) for Wet AMD
Phase 1/Phase 2 · 1 location(s) · Frontera Therapeutics · NCT06492863 Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)
Phase N/A · 8 location(s) · Ascidian Therapeutics, Inc · NCT06445322 Phase 1 Study of C.001 in Retinal Degeneration
Phase 1 · 1 location(s) · Cellio Therapeutics Inc · NCT07594236 Therapeutic Contact Lens Drug Delivery System (TCL-DDS) in Patients With Recurrent Cystoid Macular Edema
Phase 1/Phase 2 · 1 location(s) · Massachusetts Eye and Ear Infirmary · NCT04225611 A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary
Phase 3 · 56 location(s) · Kodiak Sciences Inc · NCT06996080 Efficacy and Safety of Intravitreal Injection of Bevacizumab with and Without Oral Curcumin
Phase 2/Phase 3 · 1 location(s) · Isfahan University of Medical Sciences · NCT06595355

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.